These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23229912)

  • 1. Would you rather be ill now, or later?
    Attema AE; Versteegh MM
    Health Econ; 2013 Dec; 22(12):1496-506. PubMed ID: 23229912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead time TTO: leading to better health state valuations?
    Attema AE; Versteegh MM; Oppe M; Brouwer WB; Stolk EA
    Health Econ; 2013 Apr; 22(4):376-92. PubMed ID: 22396243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deriving time discounting correction factors for TTO tariffs.
    Attema AE; Brouwer WB
    Health Econ; 2014 Apr; 23(4):410-25. PubMed ID: 23564665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of alternative variants of the lead and lag time TTO.
    Devlin N; Buckingham K; Shah K; Tsuchiya A; Tilling C; Wilkinson G; van Hout B
    Health Econ; 2013 May; 22(5):517-32. PubMed ID: 22715069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
    Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to tweak the TTO: results from a comparison of alternative specifications of the TTO.
    Versteegh MM; Attema AE; Oppe M; Devlin NJ; Stolk EA
    Eur J Health Econ; 2013 Jul; 14 Suppl 1(Suppl 1):S43-51. PubMed ID: 23900664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theoretical framework for TTO valuations of health.
    Buckingham K; Devlin N
    Health Econ; 2006 Oct; 15(10):1149-54. PubMed ID: 16786547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement.
    Attema AE; Brouwer WB
    Health Econ; 2008 Jul; 17(7):877-85. PubMed ID: 18074409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lead time tradeoff: the case of health states better than dead.
    Pinto-Prades JL; Rodríguez-Míguez E
    Med Decis Making; 2015 Apr; 35(3):305-15. PubMed ID: 25009190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of correcting values: influence and importance of correcting TTO scores for time preference.
    Attema AE; Brouwer WB
    Value Health; 2010 Dec; 13(8):879-84. PubMed ID: 20659269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correction of TTO-scores for utility curvature using a risk-free utility elicitation method.
    Attema AE; Brouwer WB
    J Health Econ; 2009 Jan; 28(1):234-43. PubMed ID: 19062114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.
    Devlin NJ; Tsuchiya A; Buckingham K; Tilling C
    Health Econ; 2011 Mar; 20(3):348-61. PubMed ID: 21308856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportional heuristics in time tradeoff and conjoint measurement.
    Stalmeier PF; Bezembinder TG; Unic IJ
    Med Decis Making; 1996; 16(1):36-44. PubMed ID: 8717597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design.
    Attema AE; Brouwer WB
    Eur J Health Econ; 2012 Aug; 13(4):491-500. PubMed ID: 21573934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.
    Kontodimopoulos N; Niakas D
    BMC Health Serv Res; 2006 Jan; 6():3. PubMed ID: 16412242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altruistic Preferences in Time Tradeoff: Consideration of Effects on Others in Health State Valuations.
    Krol M; Attema AE; van Exel J; Brouwer W
    Med Decis Making; 2016 Feb; 36(2):187-98. PubMed ID: 26552410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.